Patterson-UTI Energy Updates Q2 Guidance, Projects $220M Adjusted EBITDA and $600M Capex
Summary
Patterson-UTI Energy provided updated financial and operational guidance for Q2 2026, projecting $220 million in adjusted EBITDA and increasing full-year capital expenditures to $600 million to support growth in drilling and completion services.
Key Events
-
Updated Q2 2026 Adjusted EBITDA Guidance
The company expects consolidated adjusted EBITDA for the second quarter of 2026 to be approximately $220 million, an increase from Q1 2026.
-
Increased 2026 Capital Expenditures
Full-year 2026 capital expenditures, net of asset sales, are now projected to be approximately $600 million, with incremental investments focused on drilling rig upgrades and natural gas completions equipment.
-
Positive Operational Trends
The company anticipates exiting Q2 with 95 active rigs, increasing to over 100 by year-end, and notes mid-single digit percentage increases in leading edge drilling dayrates and stronger-than-anticipated pricing tailwinds in completion services.
-
Debt Management Update
Patterson-UTI Energy expects to redeem all of its 3.95% Senior Notes due 2028 on or about June 4, 2026, following its recent $500 million senior notes offering.
Analysis
This 8-K provides a comprehensive update on Patterson-UTI Energy's financial outlook and operational strategy, building on previous guidance. The projected increase in Q2 adjusted EBITDA and the substantial capital expenditure plan signal management's confidence in improving market conditions and their commitment to growth. The detailed operational improvements in both drilling and completion services, coupled with proactive debt management, indicate a positive trajectory for the company. While the headline EBITDA figure was reported by news outlets on the same day, this filing provides the official and detailed context for these strategic moves.
At the time of this filing, PTEN was trading at $12.08 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $4.7B. The 52-week trading range was $5.10 to $13.08. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.